Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Statement of Comprehensive Income 

Johnson & Johnson, consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net earnings 14,066 35,153 17,941 20,878 14,714
Foreign currency translation 1,708 (3,221) (1,796) (1,079) (233)
Unrealized holding gain (loss) arising during period 2 26 (24) (4) 1
Securities, net change 2 26 (24) (4) 1
Prior service credit (cost), net of amortization (154) (149) (160) (169) 1,298
Gain (loss), net of amortization 541 (1,183) 1,854 4,318 (1,135)
Consumer settlement/curtailment 23
Effect of exchange rates 62 (90) 111 106 (229)
Employee benefit plans, net change 449 (1,399) 1,805 4,255 (66)
Unrealized gain (loss) arising during period (511) 422 454 (199) 1,000
Reclassifications to earnings (862) (569) (348) (789) (53)
Derivatives & hedges, net change (1,373) (147) 106 (988) 947
Other comprehensive income (loss), net of tax 786 (4,741) 91 2,184 649
Comprehensive income 14,852 30,412 18,032 23,062 15,363

Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Comprehensive income item Description The company
Net earnings The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Johnson & Johnson net earnings increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.
Comprehensive income Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Johnson & Johnson comprehensive income increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.